BioMarin Pharmaceutical (BMRN)
(Delayed Data from NSDQ)
$85.31 USD
+1.22 (1.45%)
Updated Jul 22, 2024 04:00 PM ET
After-Market: $85.31 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value D Growth D Momentum F VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
07/29/2024
Time: -- |
6/2024 | $0.56 | -13.67% |
Earnings Summary
For their last quarter, BioMarin Pharmaceutical (BMRN) reported earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.60 per share. This reflects a positive earnings surprise of 18.33%. Look out for BMRN's next earnings release expected on July 29, 2024. For the next earning release, we expect the company to report earnings of $0.56 per share, reflecting a year-over-year increase of 3.7%.
Earnings History
Price & Consensus
Zacks News for BMRN
Xoma (XOMA) Surges 6.4%: Is This an Indication of Further Gains?
BMRN: What are Zacks experts saying now?
Zacks Private Portfolio Services